Invention Grant
- Patent Title: N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
-
Application No.: US17034295Application Date: 2020-09-28
-
Publication No.: US11673890B2Publication Date: 2023-06-13
- Inventor: Mary Theresa Didiuk , Robert Lee Dow , David Andrew Griffith
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Richard V. Zanzalari
- Main IPC: A61K31/435
- IPC: A61K31/435 ; C07D471/10 ; C07D491/20 ; C07D519/00 ; A61K31/438 ; A61K31/519 ; A61K45/06 ; C07D487/10
Abstract:
The invention provides a compound of Formula (1)
or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3, Z, A1, L and A2 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Public/Granted literature
- US20210047325A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS Public/Granted day:2021-02-18
Information query
